台股 » 個股 » 健亞 » 籌碼相關 » 券商分點績效

健亞

(4130)
可現股當沖
  • 股價
    22.30
  • 漲跌
    --
  • 漲幅
    0.00%
  • 成交量
    40
  • 產業
    上櫃 生技醫療類股
  • 151人加入追蹤

    立即追蹤

  • 本地時間:13:35(已收盤)

     
健亞 (4130)籌碼相關-券商分點績效/獲利分析
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

«前一日     2024/04/15 ~ 2024/04/29     後一日»

券商獲利排行 - 2024/04/15 ~ 2024/04/29

券商分點績效總損益(仟)己實現(仟)未實現(仟)買賣超買張賣張均價均買均賣現價
  4.71%306.92.2304.7-15911026924.224.224.222.3
  7.89%283.30.8282.5-144414824.324.124.322.3
  8.09%139.50139.5-7017124.324.324.322.3
  7.83%104.30104.3-5505524.2024.222.3
  3.66%71.28.362.9-30508024.324.224.422.3
  5.28%63.8-1.665.3-36145024.124.224.122.3
  7.15%60.1060.1-350352402422.3
  3.46%58.62.556.1-29417024.224.224.222.3
  7.08%49.50.349.2-2622924.12424.122.3
  9.72%45.6045.6-1901924.7024.722.3
  7.19%44.9044.9-260262402422.3
  7.91%40.2040.2-2002124.224.224.222.3
  7.91%40.2040.2-2102124.2024.222.3
  8.21%39.9039.9-2002024.3024.322.3
  7.77%39.5039.5-2102124.2024.222.3
  8.08%39.2039.2-2002024.3024.322.3
  6.86%38.4038.3-1942324.324.324.322.3
  6.93%36.8-0.537.2-2112224.124.624.122.3
  5.40%35.2-0.936.1-1972724.124.224.122.3
  6.77%32.60.232.4-1822024.12424.122.3
  6.35%30.80.830.1-1552024.324.224.322.3
  8.72%27.7027.7-1201324.423.924.422.3
  5.60%27.2-1.628.8-1552024.324.524.222.3
  4.67%22.92.820.1-9112024.424.324.522.3
  4.09%22.8-1.424.1-13102324.224.324.222.3
  6.74%22.6022.6-1401423.924.423.922.3
  9.16%22.5022.5-1001024.6024.622.3
  7.05%22.10.421.7-1211324.123.724.122.3
  3.39%21.43.418-9172624.224.124.322.3
  5.67%20.1020.1-1501523.6023.622.3
  8.23%20020-1001024.3024.322.3
  7.52%20020-1101124.1024.122.3
  7.50%19.9019.9-1101124.1024.122.3
  7.45%19.8019.8-1101124.1024.122.3
  5.55%18.7-0.419.1-1031424.124.12422.3
  7.66%18.5018.5-1001024.2024.222.3
  6.77%17.8017.8-1101123.9023.922.3
  6.22%17.8017.8-1101223.82423.822.3
  5.65%17.8-0.518.2-1031324.224.324.122.3
  7.28%17.5017.5-1001024.1024.122.3
  9.90%17.2017.2-70724.8024.822.3
  6.89%16.5016.5-901024242422.3
  5.66%16.5-1.518-1021224.224.924.122.3
  7.90%15.3015.3-80824.2024.222.3
  7.45%14.4014.4-80824.1024.122.3
  7.44%14.4014.4-80824.1024.122.3
  8.15%13.9013.9-70724.3024.322.3
  5.98%12.9-0.313.2-8192424.32422.3
  6.50%12.4012.4-80823.9023.922.3
  5.02%12.20.112.1-641024.324.324.322.3

券商虧損排行 - 2024/04/15 ~ 2024/04/29

券商分點績效總損益(仟)己實現(仟)未實現(仟)買賣超買張賣張均價均買均賣現價
  -7.84%-390.90-390.9206206024.224.2022.3
  -8.04%-118.90-118.96161024.224.2022.3
  -8.11%-84.80-84.74243124.324.324.322.3
  -6.39%-80.4-0.1-80.342521024.224.224.222.3
  -8.47%-72.4-0.9-71.63335224.424.52422.3
  -5.92%-63.9-0.3-63.63745824242422.3
  -8.10%-550-552828024.324.3022.3
  -7.72%-52.20-52.22828024.224.2022.3
  -7.65%-51.80-51.82828024.124.1022.3
  -6.31%-49.60-49.63333023.823.8022.3
  -7.84%-49.40-49.42526024.224.224.122.3
  -6.59%-48-0.8-47.22430624.224.324.122.3
  -9.29%-480-482121024.624.6022.3
  -8.97%-37.40-37.41717024.524.5022.3
  -6.41%-35.60.8-36.42023324.224.124.422.3
  -7.52%-32.70-32.71818024.124.1022.3
  -8.64%-31.70-31.71515024.424.4022.3
  -8.08%-31.40-31.41616024.324.3022.3
  -8.02%-29.20-29.21515024.224.2022.3
  -7.02%-27.3-0.7-26.61316324.324.324.122.3
  -7.80%-26.40-26.41414024.224.2022.3
  -8.23%-260-261313024.324.3022.3
  -5.78%-25-0.8-24.214184242423.822.3
  -8.45%-24.70-24.71212024.424.4022.3
  -2.59%-23.9-5.4-18.58382924.324.424.222.3
  -4.74%-22.9-2.9-2010201024.224.32422.3
  -0.92%-22.4-1.1-21.2111008924.224.224.222.3
  -8.42%-20.50-20.51010024.424.4022.3
  -8.14%-19.80-19.81010024.324.3022.3
  -7.31%-19.7-0.3-19.4911224.424.524.322.3
  -7.17%-190-191011024242422.3
  -6.75%-17.80-17.81111023.923.9022.3
  -9.00%-17.70-17.788024.524.5022.3
  -7.28%-17.50-17.51010024.124.1022.3
  -7.08%-170-179100242424.322.3
  -8.42%-16.40-16.488024.424.4022.3
  -5.84%-15.5-0.5-15.1811324.224.22422.3
  -7.18%-15.50-15.5990242424.422.3
  -6.98%-15.10-15.19902424022.3
  -3.25%-15-1.2-13.87191224.224.324.222.3
  -7.43%-14.30-14.388024.124.1022.3
  -8.18%-13.90-13.977024.324.3022.3
  -7.69%-130-1377024.224.2022.3
  -8.79%-12.90-12.966024.524.5022.3
  -7.47%-12.60-12.677024.124.1022.3
  -8.61%-12.60-12.666024.424.4022.3
  -8.54%-12.50-12.566024.424.4022.3
  -4.28%-12.50.7-13.2712524.224.224.322.3
  -4.90%-11.80.4-12.2710324.12424.222.3
  -9.16%-11.30-11.355024.624.6022.3
新藥研發 浩鼎子公司抗癌新藥申請一期臨床 健亞明年完成試驗Anue鉅亨-2022/09/12
健亞 相關文章